Breast cancer, Non-Hodgkin lymphoma (NHL)
Results
Phase 3
This study looked at a drug to stop heart (cardiac) damage caused by certain chemotherapy drugs for breast cancer and non-Hodgkin lymphoma.
The study was open for people to join between 2017 and 2023. The team published the results in 2024.
Recruitment start: 1 October 2017
Recruitment end: 31 March 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr David Austin
NIHR Research for Patient Benefit (RfPB) Programme
South Tees Hospitals NHS Foundation Trust
Last reviewed: 5 June 2025
CRUK internal database number: 15403
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
